These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 38345734)

  • 1. Targeting the NLRP3 inflammasome in psoriasis.
    Chen X; Deng G; Chen K; Chen Y; Ye W; Sun P
    Int J Dermatol; 2024 Jul; 63(7):844-851. PubMed ID: 38345734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting NLRP3 (Nucleotide-Binding Domain, Leucine-Rich-Containing Family, Pyrin Domain-Containing-3) Inflammasome in Cardiovascular Disorders.
    Wang Z; Hu W; Lu C; Ma Z; Jiang S; Gu C; Acuña-Castroviejo D; Yang Y
    Arterioscler Thromb Vasc Biol; 2018 Dec; 38(12):2765-2779. PubMed ID: 30571177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic Targeting of NLRP3 Inflammasomes by Natural Products and Pharmaceuticals: A Novel Mechanistic Approach for Inflammatory Diseases.
    Jahan S; Kumar D; Chaturvedi S; Rashid M; Wahajuddin M; Khan YA; Goyal SN; Patil CR; Mohanraj R; Subramanya S; Ojha S
    Curr Med Chem; 2017; 24(16):1645-1670. PubMed ID: 28245768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The NLRP3 Inflammasome as a Pharmacological Target.
    Marchetti C
    J Cardiovasc Pharmacol; 2019 Oct; 74(4):285-296. PubMed ID: 31335445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BAY 11-7082 inhibits the NF-κB and NLRP3 inflammasome pathways and protects against IMQ-induced psoriasis.
    Irrera N; Vaccaro M; Bitto A; Pallio G; Pizzino G; Lentini M; Arcoraci V; Minutoli L; Scuruchi M; Cutroneo G; Anastasi GP; Ettari R; Squadrito F; Altavilla D
    Clin Sci (Lond); 2017 Mar; 131(6):487-498. PubMed ID: 28096316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chlorquinaldol inhibits the activation of nucleotide-binding oligomerization domain-like receptor family pyrin domain-containing protein 3 inflammasome and ameliorates imiquimod-induced psoriasis-like dermatitis in mice.
    Chen Y; Chen X; Liang S; Ou Y; Lin G; Hua L; Wu X; Zhou Y; Liu Z; Cai H; Yang Z; Hu W; Sun P
    Chem Biol Interact; 2022 Sep; 365():110122. PubMed ID: 36002070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NLRP3 inflammasome as a key driver of vascular disease.
    Takahashi M
    Cardiovasc Res; 2022 Jan; 118(2):372-385. PubMed ID: 33483732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NLRP3 and pyroptosis blockers for treating inflammatory diseases.
    Coll RC; Schroder K; Pelegrín P
    Trends Pharmacol Sci; 2022 Aug; 43(8):653-668. PubMed ID: 35513901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relevant mediators involved in and therapies targeting the inflammatory response induced by activation of the NLRP3 inflammasome in ischemic stroke.
    Xu Q; Zhao B; Ye Y; Li Y; Zhang Y; Xiong X; Gu L
    J Neuroinflammation; 2021 May; 18(1):123. PubMed ID: 34059091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NLRP3 Inflammasome in Acute Myocardial Infarction.
    Mauro AG; Bonaventura A; Mezzaroma E; Quader M; Toldo S
    J Cardiovasc Pharmacol; 2019 Sep; 74(3):175-187. PubMed ID: 31356555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in the NEK7-licensed NLRP3 inflammasome activation: Mechanisms, role in diseases and related inhibitors.
    Zhao N; Li CC; Di B; Xu LL
    J Autoimmun; 2020 Sep; 113():102515. PubMed ID: 32703754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation and Function of the Nucleotide Binding Domain Leucine-Rich Repeat-Containing Receptor, Pyrin Domain-Containing-3 Inflammasome in Lung Disease.
    Lee S; Suh GY; Ryter SW; Choi AM
    Am J Respir Cell Mol Biol; 2016 Feb; 54(2):151-60. PubMed ID: 26418144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phytochemicals as Novel Therapeutic Strategies for NLRP3 Inflammasome-Related Neurological, Metabolic, and Inflammatory Diseases.
    Pellegrini C; Fornai M; Antonioli L; Blandizzi C; Calderone V
    Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31200447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological targeting of NLRP3 deubiquitination for treatment of NLRP3-associated inflammatory diseases.
    Ren GM; Li J; Zhang XC; Wang Y; Xiao Y; Zhang XY; Liu X; Zhang W; Ma WB; Zhang J; Li YT; Tao SS; Wang T; Liu K; Chen H; Zhan YQ; Yu M; Li CY; Ge CH; Tian BX; Dou GF; Yang XM; Yin RH
    Sci Immunol; 2021 Apr; 6(58):. PubMed ID: 33931568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of the NLRP3 inflammasome with natural products against chemical-induced liver injury.
    Zou J; Wang SP; Wang YT; Wan JB
    Pharmacol Res; 2021 Feb; 164():105388. PubMed ID: 33359314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis E virus infection activates NOD-like receptor family pyrin domain-containing 3 inflammasome antagonizing interferon response but therapeutically targetable.
    Li Y; Yu P; Kessler AL; Shu J; Liu X; Liang Z; Liu J; Li Y; Li P; Wang L; Wang Y; Ma Z; Liu A; Wang L; Bruno MJ; de Man RA; Peppelenbosch MP; Buschow SI; Wang L; Wang Y; Pan Q
    Hepatology; 2022 Jan; 75(1):196-212. PubMed ID: 34392558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibiting NLRP3 Inflammasome Activity in Acute Myocardial Infarction: A Review of Pharmacologic Agents and Clinical Outcomes.
    Buckley LF; Libby P
    J Cardiovasc Pharmacol; 2019 Oct; 74(4):297-305. PubMed ID: 31356538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bortezomib inhibits NLRP3 inflammasome activation and NF-κB pathway to reduce psoriatic inflammation.
    Chen X; Chen Y; Ou Y; Min W; Liang S; Hua L; Zhou Y; Zhang C; Chen P; Yang Z; Hu W; Sun P
    Biochem Pharmacol; 2022 Dec; 206():115326. PubMed ID: 36326534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease.
    Abbate A; Toldo S; Marchetti C; Kron J; Van Tassell BW; Dinarello CA
    Circ Res; 2020 Apr; 126(9):1260-1280. PubMed ID: 32324502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ginsenoside Rb1 Alleviates Bleomycin-Induced Pulmonary Inflammation and Fibrosis by Suppressing Central Nucleotide-Binding Oligomerization-, Leucine-Rich Repeat-, and Pyrin Domains-Containing Protein Three Inflammasome Activation and the NF-κB Pathway.
    Liu J; Fan G; Tao N; Feng F; Meng C; Sun T
    Drug Des Devel Ther; 2022; 16():1793-1809. PubMed ID: 35719213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.